"None of the active ones had fee cuts," Ullal told MarketWatch of Vanguard's actively managed fixed-income ETFs. Vanguard's active-bond ETFs are relatively small compared to the firm's passively ...
J.P. Morgan downgraded Conmed Corporation (NYSE:CNMD) to Neutral from Overweight on Thursday after the surgical device maker exceeded Street forecasts with its Q4 2024 results, but its 2025 outlook ...
Argentinian President Milei has taken steps follow in President Trump's footsteps and withdraw his country from the World ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
The Skillman, N.J. company expects sales to rise up to 1% or fall up to 1% in 2025, based on a 2% to 4% rise in organic sales offset by a 3% headwind from unfavorable foreign exchange rates. A 1% lift ...
Eli Lilly stock rose after the drugmaker posted quarterly earnings that beat Wall Street expectations, and issued upbeat 2025 guidance. Fourth-quarter adjusted earnings came in at $5.32 a share, above ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results